Teva Pharmaceuticals Usa, INC.
UEI NEN9A34LRHJ5 CAGE 3V8D7 Active Parsippany, NJ
Other Than Small Business · Data through August 10, 2026
Obligations by fiscal year
| Fiscal year | Obligations |
|---|---|
| FY2026 (partial year) | $25.9M |
| FY2025 | $40.2M |
| FY2024 | $38.5M |
| FY2023 | $36.1M |
| FY2022 | $35.6M |
| FY2021 | $40.5M |
Agencies, NAICS, and PSC codes
| Agency | Obligations | Share |
|---|---|---|
| Department of Defense | $216.8M | 100% |
| Department of Veterans Affairs | $0 | 0% |
| NAICS code | Obligations | Share |
|---|---|---|
| 325412 — Pharmaceutical Preparation Manufacturing | $216.8M | 100% |
| 325411 — Medicinal and Botanical Manufacturing | $0 | 0% |
| PSC code | Obligations | Share |
|---|---|---|
| 6505 — Drugs and Biologicals | $216.9M | 100% |
| AN95 — R&D- Medical: Other (operational Systems Development) | -$41K | 0% |
Contract type and set-aside mix
| Contract pricing type | Obligations | Share |
|---|---|---|
| Firm Fixed Price | $216.8M | 100% |
| Set-aside type | Obligations | Share |
|---|---|---|
| Not Specified | $216.9M | 100% |
| No Set Aside Used. | -$41K | 0% |
Place of performance by state
| State | Obligations | Share |
|---|---|---|
| NJ | $216.6M | 99.9% |
| PA | $265K | 0.1% |
Largest contract actions on file
| Award | Agency | Period of performance | Obligation | Record |
|---|---|---|---|---|
| SPE2DP25F2789 · NAICS 325412 | Department of Defense | January 28, 2025 – February 4, 2025 | $5.3M | View on USAspending |
| SPE2DP25F2259 · NAICS 325412 | Department of Defense | January 16, 2025 – January 28, 2025 | $5.3M | View on USAspending |
| SPE2DP26F3586 · NAICS 325412 | Department of Defense | March 18, 2026 – March 25, 2026 | $4.0M | View on USAspending |
| SPE2DP26F1649 · NAICS 325412 | Department of Defense | January 13, 2026 – January 27, 2026 | $4.0M | View on USAspending |
| SPE2DP26F2814 · NAICS 325412 | Department of Defense | February 17, 2026 – February 24, 2026 | $4.0M | View on USAspending |
| SPE2DP25F0856 · NAICS 325412 | Department of Defense | November 14, 2024 – November 19, 2024 | $3.2M | View on USAspending |
| SPE2DP24F1238 · NAICS 325412 | Department of Defense | December 14, 2023 – December 19, 2023 | $2.4M | View on USAspending |
| SPE2DP26F0979 · NAICS 325412 | Department of Defense | December 1, 2025 – December 9, 2025 | $2.0M | View on USAspending |
| SPE2DP24F3911 · NAICS 325412 | Department of Defense | April 9, 2024 – April 30, 2024 | $1.6M | View on USAspending |
| SPE2DP24F1236 · NAICS 325412 | Department of Defense | December 14, 2023 – December 19, 2023 | $1.5M | View on USAspending |
Similar contractors
- Chartwell Rx LLC — $225.4M, Congers, NY
- Exelan Pharmaceuticals INC — $183.4M, Boca Raton, FL
- Genentech Usa, INC — $168.7M, South San Francisco, CA
- Cardinal Health 414, LLC — $143.2M, Dublin, OH
- Fresenius Kabi, LLC — $140.1M, Lake Zurich, IL
- Progenics Pharmaceuticals INC — $137.0M, North Billerica, MA
- Alvogen, INC. — $326.9M, Pine Brook, NJ
- Baxter Healthcare CORPORATION — $101.5M, Deerfield, IL
What the numbers show
100% of this contractor's obligations on file ($216.8M of $216.8M) came from a single agency, Department of Defense.
No transaction in this record used a small-business set-aside; all obligations were awarded with no set-aside or an unspecified type.
Obligations increased from $38.5M in FY2024 to $40.2M in FY2025, the last closed fiscal year.
Source: USAspending.gov, U.S. Department of the Treasury. Contract transactions FY2021–FY2026, downloaded 2026-09-18. Figures are net obligations and can include de-obligations. Department of Defense data is published with a 90-day delay. View this contractor's largest contract on USAspending.gov.
To request removal of this profile, use the contact form and select "Removal request." Requests are processed within 30 days.